WebOxford Immunotec, a medical diagnostics company, develops tests for various diseases based on its innovative T cell measurement technology. Acquired by. PerkinElmer. Abingdon, Oxfordshire, United Kingdom. 251-500. WebNov 6, 2024 · The T-SPOT.TB tuberculosis and the Accutix tick-borne disease testing services are now part of Quest Diagnostics' portfolio of innovative infectious disease testing services. As part of the transaction, Oxford Immunotec will sell T-SPOT.TB test kits and related accessories to Quest Diagnostics under the terms of a long-term supply …

Quest Diagnostics Completes Acquisition of U.S ... - Oxford Immunotec

WebMar 9, 2024 · PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2024. “Oxford Immunotec’s global role in fighting tuberculosis, particularly its … WebAug 26, 2003 · Oxford lmmunotec Limited (“OI”), a company registered in England (number ###-###-####), whose registered office is at 3 Worcester Street, Oxford, OX1 2PZ. Recitals: A) OI is developing clinical diagnostic kits for the diagnosis and monitoring of disease, based on an assay technique known as ELlSpot. pairing jaybird to macbook pro

Our Teams - Oxford Immunotec Careers

WebJan 7, 2024 · Oxford Immunotec’s leading product, the T-SPOT® .TB test, is used for diagnosing infection with Tuberculosis, the world’s largest cause of death from infectious … WebJan 7, 2024 · Oxford Immunotec has manufactured in excess of 20 million clinical T cell tests for TB infection. The T-SPOT .TB test has been approved for sale in over 50 countries, including the United... WebOxford Immunotec has acquired 3 organizations. Their most recent acquisition was Immunetics on Oct 12, 2016. They acquired Immunetics for $12M. Funding Rounds Number of Funding Rounds 7 Total Funding Amount $204.5M Oxford Immunotec has raised a total of $204.5M in funding over 7 rounds. suite bebe asher crib